Atlas Arteria responds to IFM with “reject” on takeover offer

The Atlas Arteria Group (ASX: ALX) share price is in focus after the company lodged its Supplementary Target’s Statement rejecting IFM’s takeover offer, which independent directors say undervalues the business and is below the current market price.

What did Atlas Arteria report?

• The independent directors unanimously recommend Atlas Arteria securityholders reject the $4.75 per security takeover offer from IFM.
• The Independent Expert’s Report values Atlas Arteria at $5.39–$6.20 per security, higher than the current offer.
• The offer price is below Atlas Arteria’s recent closing price of $5.04 (as at 1 June 2026).
• The IFM offer remains highly conditional and may extend up to 12 months.
• Bidder retains the right to increase the offer up to $5.10 within 12 months after the offer closes.

What else do investors need to know?

The Supplementary Target’s Statement responds directly to IFM’s Third Supplementary Bidder’s Statement, reiterating that the offer is “too low, opportunistic and highly conditional”. Atlas Arteria’s independent directors maintain that the terms do not provide an appropriate premium for control or reflect the long-term value of its international toll road portfolio.

The Board highlights that accepting the offer now would prevent shareholders from selling on market for potentially higher prices during the lengthy offer period. Securityholders are encouraged to read the full Target’s Statement and seek independent advice if considering their options.

What’s next for Atlas Arteria?

Atlas Arteria’s board will continue actively engaging with shareholders and monitoring developments related to IFM’s bid. Investors can expect ongoing updates if circumstances change or if a revised offer is made.

The company also remains focused on disciplined management and sustainable long-term value creation through its established portfolio of toll road assets in France, Germany, and the United States.

Atlas Arteria share price snapshot

Over the past 12 months, Atlas Arteria shares have declined 5%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the same period.

View Original Announcement

The post Atlas Arteria responds to IFM with “reject” on takeover offer appeared first on The Motley Fool Australia.

More reading

• TPG Telecom posts mobile growth and strong free cash flow in 2026 update
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today
• Worried about capital gains tax and ASX shares? Here’s why you shouldn’t be
• IperionX gains U.S. Army validation as titanium fasteners outperform steel

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.